These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37555752)

  • 61. Modeling the costs of hospital-acquired infections in New Zealand.
    Graves N; Nicholls TM; Morris AJ
    Infect Control Hosp Epidemiol; 2003 Mar; 24(3):214-23. PubMed ID: 12683515
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Understanding the Economic Impact of Health Care-Associated Infections: A Cost Perspective Analysis.
    Scott RD; Culler SD; Rask KJ
    J Infus Nurs; 2019; 42(2):61-69. PubMed ID: 30817421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Could the prevention of health care-associated infections increase hospital cost? The financial impact of health care-associated infections from a hospital management perspective.
    Shepard J; Frederick J; Wong F; Madison S; Tompkins L; Hadhazy E
    Am J Infect Control; 2020 Mar; 48(3):255-260. PubMed ID: 32089192
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
    Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
    BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.
    Weiner LM; Webb AK; Limbago B; Dudeck MA; Patel J; Kallen AJ; Edwards JR; Sievert DM
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1288-1301. PubMed ID: 27573805
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Paediatric bacterial meningitis in the USA: outcomes and healthcare resource utilization of nosocomial versus community-acquired infection.
    Adil SM; Hodges SE; Charalambous LT; Kiyani M; Liu B; Lee HJ; Parente BA; Perfect JR; Lad SP
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33206032
    [No Abstract]   [Full Text] [Related]  

  • 67. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses.
    Demuyser T; Seyler L; Buttiens R; Soetens O; Van Nedervelde E; Caljon B; Praet J; Seyler T; Boeckmans J; Meert J; Vanstokstraeten R; Martini H; Crombé F; Piérard D; Allard SD; Wybo I
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298847
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of whole-genome sequencing for outbreak detection of Verotoxigenic Escherichia coli O157:H7 from the Canadian perspective.
    Rumore J; Tschetter L; Kearney A; Kandar R; McCormick R; Walker M; Peterson CL; Reimer A; Nadon C
    BMC Genomics; 2018 Dec; 19(1):870. PubMed ID: 30514209
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Economic burden attributable to healthcare-associated infections at western China hospitals: 6 Year, prospective cohort study.
    Lv Y; Huang X; Wu J; Xiao X; Ma C; Jiang X; Zhou P; Liu L; Jiang Y; Zou A; Niu H; Sun J; Hou L; Wang X; Dai Y; Peng S; Deng X; Xia H; Guo Y; Wang D; Huang T; Li C; He L; Xiong F; Xiong H; Cao H; Lu J; Liu X; Jian X; Luo W; An Y; Wu Y; Deng K; Kang X; Chen X; Tang B; Li L; Xiang Q
    J Infect; 2024 Feb; 88(2):112-122. PubMed ID: 38135161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. What will the cardiovascular disease slowdown cost? Modelling the impact of CVD trends on dementia, disability, and economic costs in England and Wales from 2020-2029.
    Collins B; Bandosz P; Guzman-Castillo M; Pearson-Stuttard J; Stoye G; McCauley J; Ahmadi-Abhari S; Araghi M; Shipley MJ; Capewell S; French E; Brunner EJ; O'Flaherty M
    PLoS One; 2022; 17(6):e0268766. PubMed ID: 35767575
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical, operational, and financial impact of an ultraviolet-C terminal disinfection intervention at a community hospital.
    Raggi R; Archulet K; Haag CW; Tang W
    Am J Infect Control; 2018 Nov; 46(11):1224-1229. PubMed ID: 29934205
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incidence of healthcare-associated infections in a tertiary hospital in Beijing, China: results from a real-time surveillance system.
    Zhang Y; Du M; Johnston JM; Andres EB; Suo J; Yao H; Huo R; Liu Y; Fu Q
    Antimicrob Resist Infect Control; 2019; 8():145. PubMed ID: 31467671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
    Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
    Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HEALTHCARE-ASSOCIATED INFECTIONS AT SELECTED HOSPITALS IN THAILAND.
    Manosuthi W; Thientong V; Moolasart V; Rongrungrueng Y; Sangsajja C; Danchaivijitr S
    Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):204-12. PubMed ID: 29644841
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.
    Zimlichman E; Henderson D; Tamir O; Franz C; Song P; Yamin CK; Keohane C; Denham CR; Bates DW
    JAMA Intern Med; 2013 Dec 9-23; 173(22):2039-46. PubMed ID: 23999949
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel, integrated approach for understanding and investigating Healthcare Associated Infections: A risk factors constellation analysis.
    Carestia M; Andreoni M; Buonomo E; Ciccacci F; De Angelis L; De Carolis G; De Filippis P; Di Giovanni D; Emberti Gialloreti L; Fontana C; Guarente L; Magrini A; Mattei M; Moramarco S; Morciano L; Mosconi C; Orlando S; Quintavalle G; Riccardi F; Santoro V; Palombi L
    PLoS One; 2023; 18(3):e0282019. PubMed ID: 36961857
    [TBL] [Abstract][Full Text] [Related]  

  • 78. What is the cost-effectiveness of menu calorie labelling on reducing obesity-associated cancer burdens? An economic evaluation of a federal policy intervention among 235 million adults in the USA.
    Du M; Griecci CF; Cudhea F; Eom H; Wong JB; Wilde P; Kim DD; Michaud DS; Wang YC; Mozaffarian D; Zhang FF;
    BMJ Open; 2023 Apr; 13(4):e063614. PubMed ID: 37072239
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epidemiology and economic impact of health care-associated infections and cost-effectiveness of infection control measures at a Thai university hospital.
    Rattanaumpawan P; Thamlikitkul V
    Am J Infect Control; 2017 Feb; 45(2):145-150. PubMed ID: 27665034
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.